Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cend-1 (1 trial)
gemcitabine (gemzar) (1 trial)
paclitaxel (taxol) (1 trial)
Adenocarcinoma (Phase 1)
Pancreatic Neoplasms (Phase 1)
Trials (1 total)
Trial APIs (3 total)